Michael F. Price’s Ironwood Pharmaceuticals IRWD Stock Holding History

Michael F. Price’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$6.55M	Hold	520,000	–	–	0.77%	41
2021 Q4	$6.06M	Hold	520,000	–	–	0.67%	41
2021 Q3	$6.79M	Hold	520,000	–	–	0.79%	40
2021 Q2	$6.69M	Hold	520,000	–	–	0.74%	39
2021 Q1	$5.81M	Buy	520,000 +18,126	+4%	+$191K	0.7%	38
2020 Q4	$5.72M	Hold	501,874	–	–	0.88%	31
2020 Q3	$4.51M	Buy	501,874 +92,374	+23%	+$918K	0.82%	32
2020 Q2	$4.23M	Buy	409,500 +369,500	+924%	+$3.78M	0.77%	33
2020 Q1	$404K	Buy	+40,000	New	+$470K	0.08%	82
2019 Q3	–	Sell	-8,358	Closed	-$91K	–	126
2019 Q2	$91K	Buy	+8,358	New	+$93.6K	0.01%	106

Other funds holding IRWD

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Michael F. Price's IRWD Position: Q1 2022 in Review

Michael F. Price held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2022 at 520,000 shares worth $6.55M. The position accounts for 0.77% of the portfolio, ranked #41.

Michael F. Price first reported a position in IRWD in Q2 2019 and has held it in 10 quarters since. The position peaked at $6.79M in Q3 2021. 221 funds tracked by Wall St. Rank hold IRWD as of Q1 2022.

Michael F. Price held 520,000 shares of Ironwood Pharmaceuticals worth $6.55M as of Q1 2022.
Michael F. Price left its Ironwood Pharmaceuticals share count unchanged in Q1 2022.
Ironwood Pharmaceuticals made up 0.77% of Michael F. Price's portfolio in Q1 2022, its #41 holding.
Michael F. Price first reported a position in Ironwood Pharmaceuticals in Q2 2019 and has held it in 10 quarters since.
Michael F. Price's Ironwood Pharmaceuticals position peaked at $6.79M in Q3 2021.
221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2022.

Based on Michael F. Price's 13F filing for Q1 2022, filed 16 May 2022.